Akimichi Morita
Akimichi Morita, MD, PhD is an expert in Dermatology at Nagoya City University (Japan). As of October 2026, ScienceLeadR ranks Akimichi Morita in the top 1% of experts worldwide for Psoriasis and Skin Diseases, Papulosquamous. Akimichi Morita has authored 609 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 3 of them ongoing. SLR score: 2,849 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Public Health - Immunology - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Professor Akimichi Morita graduated from Nagoya City University and received his MD in 1989. He later received his Ph.D. in basic immunology from Aichi Cancer Center in Nagoya. As a Humboldt Foundation Fellow, he studied photobiology and photoimmunology at Düsseldorf University in Düsseldorf, Germany, and underwent further training at the University of Texas Southwestern Medical Center in Dallas, TX, USA. Since then, he has introduced numerous standard phototherapies to Japan. He was appointed Professor and Chairman of the Department of Geriatric and Environmental Dermatology at Nagoya City University Graduate School of Medical Sciences in 2003 and currently holds the position of Vice Director of Nagoya City University Hospital. Professor Morita’s main research interests are photobiology, phototherapy, cutaneous immunology, skin aging, cutaneous T-cell lymphoma, and psoriasis.
Professor Morita holds the title of President at the Japanese Society for Psoriasis Research (2022-) and is a board of directors for the International Council of Psoriasis (IPC, 2023-). He was the President of the Japanese Society for Photomedicine and Photobiology (2018-2022) and the President of the Japanese Society for Investigative Dermatology (JSID)(2017-2020). He is an editorial board member of several prestigious medical journals and currently serves as Editor-in-Chief of Experimental Dermatology. He also served as Editor-in-Chief of the journal Photodermatology, Photomedicine & Photoimmunology (2018-2021) and Editor-in-Chief of the Journal of Dermatological Science(2008-2013). In addition, he has published over 300 articles in peer-reviewed journals (H-index: 56) and has written 26 books or book chapters.
Organizations
Career arc: 1989 - 2026
Number : 609
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 19
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis NCT07286058 — arthritis, psoriatic, safety, pharmaceutical preparations, arthritis, tablets, drug therapy, therapeutics | Phase 3 | Recruiting | 2026 |
| A Long Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis NCT07250802 — safety, pharmaceutical preparations, drug therapy, aged, therapeutics, psoriasis, child, pharmacokinetics | Phase 3 | Recruiting | 2025 |
| A Study of Zasocitinib in Adults With Nonsegmental Vitiligo NCT07108283 — skin, safety, pharmaceutical preparations, vitiligo, drug therapy, capsules, immune system, therapeutics | Phase 2 | Recruiting | 2025 |
LeadR Networks
Main global connection map